Monthly Archives: April 2019

Vermilion Energy (VET) Received its Third Buy in a Row

Analysts have been quite happy with Vermilion Energy (VET – Research Report) stock lately, as after Canaccord Genuity and Raymond James rated the stock a Buy this past month, there is another positive note, this time from GMP FirstEnergy. The

The EVP-Government Programs of Iridium Communications is Exercising Options

Yesterday it was reported that the EVP-Government Programs of Iridium Communications (IRDM – Research Report), Scott Scheimreif, exercised options to sell 79,078 IRDM shares at $8.73 a share, for a total transaction value of $2.15M. Following Scott Scheimreif’s last IRDM

Oppenheimer Maintains Their Buy Rating on Fiserv (FISV)

In a report released yesterday, Glenn Greene from Oppenheimer maintained a Buy rating on Fiserv (FISV – Research Report), with a price target of $97. The company’s shares closed yesterday at $87.24. Greene commented: “Fiserv posted solid 1Q19 results with

Amgen Inc (AMGN) Gets a Buy Rating from Cowen & Co.

In a report released yesterday, Yaron Werber from Cowen & Co. maintained a Buy rating on Amgen Inc (AMGN – Research Report), with a price target of $229. The company’s shares closed yesterday at $179.32. According to TipRanks.com, Werber is

The EVP & CFO of PulteGroup (NYSE: PHM) is Selling Shares

Yesterday, the EVP & CFO of PulteGroup (PHM – Research Report), Robert Oshaughnessy, sold shares of PHM for $3.01M. In addition to Robert Oshaughnessy, one other PHM executive reported Sell trades in the last month. See today’s analyst top recommended

Vertex Pharmaceuticals (VRTX) Gets a Buy Rating from Cowen & Co.

In a report released yesterday, Phil Nadeau from Cowen & Co. maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with a price target of $220. The company’s shares closed yesterday at $168.98. According to TipRanks.com, Nadeau is